Document:

EX-10.10

 Exhibit 10.10 

INDEMNIFICATION AGREEMENT 
 THIS
INDEMNIFICATION AGREEMENT (the “Agreement”), dated as of __________, 202[__], is entered into by and between Alpha Tau Medical Ltd., an Israeli company whose address is 5 Kiryat HaMada St., Jerusalem, Israel (the
“Company”), and the undersigned Director or Officer of the Company whose name appears on the signature page hereto officer (the “Indemnitee”). 

 

	WHEREAS, 	 Indemnitee is an Office Holder (“Nosse Misra”), as such term is defined in the Companies Law,
5759–1999, as amended (the “Office Holder” and the “Companies Law” respectively), of the Company; 

  

	WHEREAS, 	 both the Company and Indemnitee recognize the increased risk of litigation and other claims being asserted
against Office Holders of companies and that highly competent persons have become more reluctant to serve corporations as directors and officers or in other capacities unless they are provided with adequate protection through insurance or adequate
indemnification against inordinate risks of claims and actions against them arising out of their service to, and activities on behalf of, companies; 

  

	WHEREAS, 	 the Amended and Restated Articles of Association of the Company (the “Articles of
Association”) authorize the Company to indemnify and advance expenses to its Office Holders and provide for insurance and exculpation to its Office Holders, in each case, to the fullest extent permitted by applicable law;

  

	WHEREAS, 	 the Company has determined that (i) the increased difficulty in attracting and retaining competent persons
is detrimental to the best interests of the Company’s shareholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the future, and (ii) it is reasonable, prudent and
necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law, so that they will serve or continue to serve the Company free from undue
concern that they will not be so indemnified; and 

  

	WHEREAS, 	 in recognition of Indemnitee’s need for substantial protection against personal liability in order to
assure Indemnitee’s continued service to the Company in an effective manner and, in part, in order to provide Indemnitee with specific contractual assurance that the indemnification, insurance and exculpation afforded by the Articles of
Association will be available to Indemnitee, the Company wishes to undertake in this Agreement for the indemnification of, and the advancing of expenses to, Indemnitee to the fullest extent permitted by applicable law and as set forth in this
Agreement and provide for insurance and exculpation of Indemnitee as set forth in this Agreement. 

  

	NOW,	 THEREFORE,  the parties hereto agree as follows: 

 

	1.	 INDEMNIFICATION AND INSURANCE. 

 

	 	1.1.	 The Company hereby undertakes to indemnify Indemnitee to the fullest extent permitted by applicable law for any
liability and expense specified in Sections 1.1.1 through 1.1.4 below, imposed on Indemnitee due to or in connection with an act performed by such Indemnitee, either prior to or after the date hereof, in Indemnitee’s capacity as an Office
Holder, including, without limitation, as a director, officer, employee, agent or fiduciary of the Company, any subsidiary thereof or any other corporation, collaboration, partnership, joint venture, trust or other enterprise, in which Indemnitee
serves at any time at the request of the Company (the “Corporate Capacity”). The term “act performed in Indemnitee’s capacity as an Office Holder” shall include, without limitation, any act, omission or failure to act
and any other circumstances relating to or arising from Indemnitee’s service in a Corporate Capacity. Notwithstanding the foregoing, in the event that the Office Holder is the beneficiary of an indemnification undertaking provided by a
subsidiary of the Company or any other entity with respect to his or her Corporate Capacity with such subsidiary or entity, then the indemnification 

	 	
obligations of the Company hereunder with respect to such Corporate Capacity shall only apply to the extent that the indemnification by such subsidiary or other entity does not actually fully
cover the indemnifiable liabilities and expenses relating thereto. The following shall be hereinafter referred to as “Indemnifiable Events”: 

  

	 	1.1.1.	 Financial liability imposed on Indemnitee in favor of any person pursuant to a judgment, including a judgment
rendered in the context of a settlement or an arbitrator’s award approved by a court. For purposes of Section 1 of this Agreement, the term “person” shall include, without limitation, a natural person, firm, partnership,
joint venture, trust, company, corporation, limited liability entity, unincorporated organization, estate, government, municipality, or any political, governmental, regulatory or similar agency or body; 

 

	 	1.1.2.	 Reasonable Expenses (as defined below) expended by Indemnitee as a result of an investigation or any proceeding
instituted against the Indemnitee by an authority that is authorized to conduct such investigation or proceeding, and that was concluded without filing an indictment against the Indemnitee and without imposing on the Indemnitee a financial liability
in lieu of a criminal proceeding, or that was concluded without filing an indictment against the Indemnitee but imposing a financial liability in lieu of a criminal proceeding in an offence that does not require proof of mens rea, or in
connection with a financial sanction. In this section “conclusion of a proceeding without filing an indictment in a matter in which a criminal investigation has been instigated” and “financial liability in lieu of a criminal
proceeding” shall have the meaning assigned to such terms under the Companies Law, and the term “financial sanction” shall mean such term as referred to in Section 260(a)(1a) of the Companies Law; 

 

	 	1.1.3.	 Reasonable Expenses expended by or imposed on Indemnitee by a court, in a proceeding instituted against
Indemnitee by the Company or on its behalf or by another person, or in a criminal charge from which Indemnitee was acquitted or in which Indemnitee convicted of an offence that does not require proof of mens rea; and

  

	 	1.1.4.	 Any other event, occurrence, matter or circumstances under any law with respect to which the Company may, or
will be able to, indemnify an Office Holder (including, without limitation, in accordance with Section 56h(b)(1) of the Israeli Securities Law 5728-1968 (the “Israeli Securities Law”), if applicable, and
Section 50P(b)(2) of the Israeli Economic Competition Law, 5758-1988 (the “Economic Competition Law”)). 

For the purpose of this Agreement, “Expenses” shall include, without limitation, reasonable legal fees and all other costs,
expenses and obligations paid or incurred by Indemnitee in connection with investigating, defending, being a witness in or participating in (including on appeal), or preparing to defend, be a witness in or participate in any claim, action, suit,
proceeding, alternative dispute resolution mechanism, hearing, inquiry or investigation relating to any matter for which indemnification hereunder may be provided. Expenses shall be considered paid or incurred by Indemnitee at such time as
Indemnitee is required to pay or incur such cost or expenses, including upon receipt of an invoice or payment demand. The Company shall pay the Expenses in accordance with the provisions of Section 1.3. 

 

	 	1.2.	 Notwithstanding anything herein to the contrary, the Company’s undertaking to indemnify the Indemnitee
under Section 1.1.1 shall only be with respect to events described in Exhibit A hereto. The Board of Directors of the Company (the “Board”) has determined that the categories of events listed in Exhibit A are
foreseeable in light of the operations of the Company. The maximum amount of indemnification payable by the Company under Section 1.1.1 with respect to the specific events described in Exhibit A

  
 - 2 - 

	 	
during any period of five years, shall be as set forth in Exhibit A hereto (the “Limit Amount”). If the Company undertook to indemnify multiple persons under agreements
concurrently in effect similar to this Agreement (the “Indemnifiable Persons”) the Limit Amount for the five year period commencing on the closing of the first issuance and sale of the Company’s ordinary shares to the public,
pursuant to an effective registration statement under the United States Securities Act 1933, as amended, or the securities law of any other jurisdiction, and for every subsequent five year period, shall apply to all Indemnifiable Persons, in the
aggregate, and if the Limit Amount is insufficient to cover all the indemnity amounts payable with respect to all Indemnifiable Persons during the relevant five year period, then such amount shall be allocated to such Indemnifiable Persons pro rata
according to the percentage of their culpability, as finally determined by a court in the relevant claim, or, absent such determination or in the event such persons are parties to different claims, based on an equal pro rata allocation among such
Indemnifiable Persons. The Limit Amount payable by the Company as described in Exhibit A is deemed by the Company to be reasonable in light of the circumstances. The indemnification provided under Section 1.1.1 herein shall not be subject to
the limitations imposed by this Section 1.2 and Exhibit A if, and to the extent that, such limits do not or are no longer required by the Companies Law. 

 

	 	1.3.	 If so requested by Indemnitee in writing, and subject to the Company’s repayment and reimbursements rights
set forth in Sections 3 and 5 below, the Company shall pay amounts to cover Indemnitee’s Expenses with respect to which Indemnitee is entitled to be indemnified under Section 1.1 above, as and when incurred. The payments of such amounts
shall be made by the Company directly to the Indemnitee’s legal and other advisors, as soon as practicable, but in any event no later than fifteen (15) days after written demand by such Indemnitee therefor to the Company, and any such
payment shall be deemed to constitute indemnification hereunder. As part of the aforementioned undertaking, the Company will make available to Indemnitee any security or guarantee that Indemnitee may be required to post in accordance with an interim
decision given by a court, governmental or administrative body, or an arbitrator, including for the purpose of substituting liens imposed on Indemnitee’s assets. 

 

	 	1.4.	 The Company’s obligation to indemnify Indemnitee and advance Expenses in accordance with this Agreement
shall be for such period (the “Indemnification Period”) as Indemnitee shall be subject to any actual, possible or threatened claim, action, suit, demand or proceeding or any inquiry or investigation, whether civil, criminal or
investigative, arising out of the Indemnitee’s service in the Corporate Capacity as described in Section 1.1 above, whether or not Indemnitee is still serving in such position. 

 

	 	1.5.	 The Company undertakes that, subject to the mandatory limitations under applicable law, as long as it may be
obligated to provide indemnification and advance Expenses under this Agreement, the Company will purchase and maintain in effect directors and officers liability insurance, which will include coverage for the benefit of the Indemnitee, providing
coverage in amounts as reasonably determined by the Board; provided that, the Company shall have no obligation to obtain or maintain directors and officers insurance policy if the Company determines in good faith that such insurance is not
reasonably available, the premium costs for such insurance are disproportionate to the amount of coverage provided, or the coverage provided by such insurance is so limited by exclusions that it provides an insufficient benefit. The Company hereby
undertakes to notify the Indemnitee 30 days prior to the expiration or termination of the directors and officers liability insurance, to the extent it is reasonably practicable to do so.  

 

	 	1.6.	 The Company undertakes to give prompt written notice of the commencement of any claim hereunder to the insurers
in accordance with the procedures set forth in each of the policies. The Company shall thereafter diligently take all actions reasonably necessary under the circumstances to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as
a result of such action, suit, proceeding, inquiry or investigation in 

  
 - 3 - 

	 	
accordance with the terms of such policies. The above shall not derogate from Company’s authority to freely negotiate or reach any compromise with the insurer which is reasonable at the
Company’s sole discretion provided that the Company shall act in good faith and in a diligent manner.  

  

	2.	 SPECIFIC LIMITATIONS ON INDEMNIFICATION. 

Notwithstanding anything to the contrary in this Agreement, the Company shall not indemnify or advance Expenses to Indemnitee with respect to
(i) any act, event or circumstance with respect to which it is prohibited to do so under applicable law, or (ii) a counter claim made by the Company or in its name in connection with a claim against the Company filed by the Indemnitee.

  

	3.	 REPAYMENT OF EXPENSES. 

 

	 	3.1.	 In the event that the Company provides or is required to provide indemnification with respect to Expenses
hereunder and at any time thereafter the Company determines, based on advice from its legal counsel, that the Indemnitee was not entitled to such payments, the amounts so indemnified by the Company will be promptly repaid by Indemnitee, unless the
Indemnitee disputes the Company’s determination, in which case the Indemnitee’s obligation to repay to the Company shall be postponed until such dispute is resolved. 

 

	 	3.2.	 Indemnitee’s obligation to repay to the Company for any Expenses or other sums paid hereunder shall be
deemed as a loan given to Indemnitee by the Company subject to the minimum interest rate prescribed by Section 3(9) of the Income Tax Ordinance [New Version], 1961, or any other legislation replacing it, which is not considered a taxable
benefit. 

  

	4.	 SUBROGATION. 

In the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of
Indemnitee, who shall execute all documents required and shall do everything that may be necessary to secure such rights, including the execution of such documents necessary to enable the Company effectively to bring suit to enforce such rights.

  

	5.	 REIMBURSEMENT. 

The Company shall not be liable under this Agreement to make any payment in connection with any Indemnifiable Event to the extent Indemnitee
has otherwise actually received payment under any insurance policy or otherwise (without any obligation of Indemnitee to repay any such amount) of the amounts otherwise indemnifiable hereunder. Any amounts paid to Indemnitee under such insurance
policy or otherwise after the Company has indemnified Indemnitee for such liability or Expense shall be repaid to the Company promptly upon receipt by Indemnitee, in accordance with the terms set forth in Section 3.2. 

The Company hereby acknowledges that the Indemnitee has now, or may have in the future, certain rights to indemnification, advancement of
expenses and/or insurance provided by third parties (the “Secondary Indemnitor”), and the Company hereby agrees (i) that the Company is the indemnitor of first resort (i.e., its obligations to the Indemnitee are primary and any
obligation of any Secondary Indemnitor to advance expenses or to provide indemnification for the same expenses or liabilities incurred by the Indemnitee are secondary), (ii) it shall be required to advance the full amount of expenses incurred
by the Indemnitee and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement to the fullest extent legally permitted and as required by the terms of this Agreement and/or the Articles of
Association (or any other agreement between the Company and the Indemnitee), without regard to any rights the Indemnitee may have against the Secondary Indemnitors, and (iii) that it irrevocably waives, relinquishes and releases any Secondary
Indemnitor from any and all claims against any Secondary Indemnitor for contribution, subrogation or any other recovery of any kind of respect of the subject matters of this Agreement. Without altering or expanding any of the

  
 - 4 - 

 
Company’s indemnification obligations hereunder, the Company further agrees that no advancement or payment by any Secondary Indemnitor on the Indemnitee’s behalf with respect to any
claim for which Indemnitee has sought indemnification from the Company shall affect the foregoing and any Secondary Indemnitor shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights
of recovery of the Indemnitee against the Company. The Company and the Indemnitee agree that the Secondary Indemnitors are express third party beneficiaries of the terms of this Section 5. 

 

	6.	 EFFECTIVENESS. 

The Company represents and warrants that this Agreement is valid, binding and enforceable in accordance with its terms and was duly adopted and
approved by the Company, and shall be in full force and effect immediately upon its execution. 
  

	7.	 NOTIFICATION AND DEFENSE OF CLAIM. 

Indemnitee shall notify the Company in writing of the commencement of any action, suit or proceeding, and of the receipt of any notice or
threat that any such legal proceeding has been or shall or may be initiated against Indemnitee (including any proceedings by or against the Company and any subsidiary thereof), promptly upon Indemnitee first becoming so aware; but the omission so to
notify the Company will not relieve the Company from any liability which it may have to Indemnitee under this Agreement unless and to the extent that such failure to provide notice prejudices the Company’s ability to defend such action. Notice
to the Company shall be directed to the Chief Executive Officer or Chief Financial Officer of the Company at the address shown in the preamble to this Agreement (or such other address as the Company shall designate in writing to Indemnitee). With
respect to any such action, suit or proceeding as to which Indemnitee notifies the Company of the commencement thereof and without derogating from Sections 1.1 and 2: 
  

	 	7.1.	 The Company will be entitled to participate therein at its own expense. 

 

	 	7.2.	 Except as otherwise provided below, the Company, alone or jointly with any other indemnifying party similarly
notified, will be entitled to assume the defense thereof, with counsel selected by the Company. Indemnitee shall have the right to employ his or her own counsel in such action, suit or proceeding, but the fees and expenses of such counsel incurred
after notice from the Company of its assumption of the defense thereof shall be at the expense of Indemnitee, unless: (i) the employment of counsel by Indemnitee has been authorized in writing by the Company; (ii) the Company, in good
faith, reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct of the defense of such action; or (iii) the Company has not in fact employed counsel to assume the defense of such action
within reasonable time, in which cases the reasonable fees and expenses of Indemnitee’s counsel shall be at the expense of the Company. The Company shall not be entitled to assume the defense of any action, suit or proceeding brought by or on
behalf of the Company or as to which Indemnitee and the Company shall have reached the conclusion specified in (ii) above. 

  

	 	7.3.	 The Company shall not be liable to indemnify Indemnitee under this Agreement for any amounts or expenses paid
in connection with a settlement of any action, claim or otherwise, effected without the Company’s prior written consent. 

  

	 	7.4.	 The Company shall have the right to conduct the defense as it sees fit in its sole discretion (provided that
the Company shall conduct the defense in good faith and in a diligent manner), including the right to settle or compromise any claim or to consent to the entry of any judgment against Indemnitee without the consent of the Indemnitee, provided that,
the amount of such settlement, compromise or judgment does not exceed the Limit Amount (if applicable) and is fully indemnifiable pursuant to this Agreement (subject to Section 1.2 of this Agreement) and/or applicable law, and any such
settlement, compromise or judgment does not impose any penalty or limitation on Indemnitee without the Indemnitee’s prior written consent. The Indemnitee’s consent shall not be

  
 - 5 - 

	 	
required if the settlement includes a complete release of Indemnitee, does not contain any admission of wrong-doing by Indemnitee, and includes monetary sanctions only as provided above. In the
case of criminal proceedings, the Company and/or its legal counsel will not have the right to plead guilty or agree to a plea-bargain in the Indemnitee’s name without the Indemnitee’s prior written consent. Neither the Company nor
Indemnitee will unreasonably withhold or delay their consent to any proposed settlement. 

  

	 	7.5.	 Indemnitee shall fully cooperate with the Company and shall give the Company all information and access to
documents, files and to his or her advisors and representatives as shall be within Indemnitee’s power, in every reasonable way as may be useful to the Company with respect to any claim which is the subject matter of this Agreement and in the
defense of other claims asserted against the Company (other than claims asserted by Indemnitee), provided that the Company shall cover all expenses, costs and fees incidental thereto such that the Indemnitee will not be required to pay or bear such
expenses, costs and fees. 

  

	8.	 EXCULPATION. 

Subject to the provisions of the Companies Law, the Company hereby releases, in advance, the Indemnitee from liability to the Company for any
damage that arises from the breach of the Office Holder’s duty of care (within the meaning of such terms under Sections 252 and 253 of the Companies Law), other than breach of the duty of care towards the Company in a distribution (as such term
is defined in the Companies Law). 
  

	9.	 NON-EXCLUSIVITY. 

The rights of the Indemnitee hereunder shall not be deemed exclusive of any other rights Indemnitee may have under the Articles of Association,
applicable law or otherwise, and to the extent that during the Indemnification Period the indemnification rights of the then serving directors and officers are more favorable to such directors or officers than the indemnification
rights provided under this Agreement to Indemnitee, Indemnitee shall be entitled to the full benefits of such more favorable indemnification rights to the extent permitted by law. 

 

	10.	 PARTIAL INDEMNIFICATION. 

If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of the expenses,
judgments, fines or penalties actually or reasonably incurred by Indemnitee in connection with any proceedings, but not, however, for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion of such expenses,
judgments, fines or penalties to which Indemnitee is entitled under any provision of this Agreement. Subject to the provisions of Section 5 above, any amount received by Indemnitee (under any insurance policy or otherwise) shall not reduce the
Limit Amount hereunder and shall not derogate from the Company’s obligation to indemnify the Indemnitee in accordance with the provisions of this Agreement up to the Limit Amount, as set forth in Section 1.2. 

 

	11.	 BINDING EFFECT. 

This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors and
permitted assigns. In the event of a merger or consolidation of the Company or a transfer or disposition of all or substantially all of the business or assets of the Company, the Indemnitee shall be entitled to the same indemnification and insurance
provisions as the most favorable indemnification and insurance provisions afforded to the then-serving Office Holders of the Company. In the event that in connection with such transaction the Company purchases a directors and officers’
“tail” or “run-off” policy for the benefit of its then serving Office Holders, then such policy shall cover Indemnitee and such coverage shall be deemed to be in satisfaction of the
insurance requirements under this Agreement. This Agreement shall continue in effect during the Indemnification Period regardless of whether Indemnitee continues to serve in a Corporate Capacity. 

  
 - 6 - 

 Any amendment to the Companies Law, the Israeli Securities Law, the Economic Competition Law
or other applicable law adversely affecting the right of the Indemnitee to be indemnified, insured or released pursuant hereto shall be prospective in effect, and shall not affect the Company’s obligation or ability to indemnify or insure the
Indemnitee for any act or omission occurring prior to such amendment, unless otherwise provided by applicable law. 
  

	12.	 SEVERABILITY. 

The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the
validity or enforceability of the other provisions hereof. If any provision of this Agreement, or the application thereof or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in
order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement and the application of such provision or circumstances shall not be affected
by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction. 

 

	13.	 NOTICE. 

All notices and other communications pursuant to this Agreement shall be in writing and shall be deemed provided if delivered personally,
telecopied, sent by electronic facsimile, email, reputable overnight courier or mailed by registered or certified mail (return receipt requested), postage prepaid, to the parties at the addresses shown in the preamble to this Agreement, or to such
other address as the party to whom notice is to be given may have furnished to the other party hereto in writing in accordance herewith. Any such notice or communication shall be deemed to have been delivered and received (i) in the case of
personal delivery, on the date of such delivery, (ii) in the case of telecopier or an electronic facsimile or email, one business day after the date of transmission if confirmation of receipt is received, (iii) in the case of a reputable
overnight courier, three business days after deposit with such reputable overnight courier service, and (iv) in the case of mailing, on the seventh business day following that on which the mail containing such communication is posted. 

 

	14.	 GOVERNING LAW; JURISDICTION. 

This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Israel, without giving effect to the
conflicts of law provisions of those laws. The Company and Indemnitee each hereby irrevocably consent to the exclusive jurisdiction and venue of the courts of Tel Aviv, Israel for all purposes in connection with any action or proceeding which arises
out of or relates to this Agreement. 
  

	15.	 ENTIRE AGREEMENT. 

This Agreement represents the entire agreement between the parties and supersedes any other agreements, contracts or understandings between the
parties, whether written or oral, with respect to the subject matter of this Agreement, including, for the avoidance of doubt, any previous indemnification executed between the parties. 

 

	16.	 NO MODIFICATION AND NO WAIVER. 

No supplement, modification or amendment, termination or cancellation of this Agreement shall be binding unless executed in writing by both of
the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver. Any waiver shall be
in writing. The Company hereby undertakes not to amend its Articles of Association in a manner which will adversely affect the provisions of this Agreement. 

  
 - 7 - 

	17.	 ASSIGNMENTS; NO THIRDPARTY RIGHTS 

Neither party hereto may assign any of its rights or obligations hereunder except with the express prior written consent of the other party.
Nothing herein shall be deemed to create or imply an obligation for the benefit of a third party, except as expressly provided herein. Without limitation of the foregoing, nothing herein shall be deemed to create any right of any insurer that
provides directors’ and officers’ liability insurance, to claim, on behalf of Indemnitee, any rights hereunder. 
  

	18.	 INTERPRETATION; DEFINITIONS. 

Unless the context shall otherwise require: words in the singular shall also include the plural, and vice versa; any pronoun shall include the
corresponding masculine, feminine and neuter forms; the words “include”, “includes” and “including” shall be deemed to be followed by the phrase “without limitation”; the words “herein”,
“hereof” and “hereunder” and words of similar import refer to this Agreement in its entirety and not to any part hereof; all references herein to Sections or clauses shall be deemed references to Sections or clauses of this
Agreement; any references to any agreement or other instrument or law, statute or regulation are to it as amended, supplemented or restated, from time to time (and, in the case of any law, to any successor provisions or re-enactment or modification thereof being in force at the time); any reference to “law” shall include any supranational, national, federal, state, local, or foreign statute or law and all rules and
regulations promulgated thereunder; any reference to a “day” or a number of “days” (without any explicit reference otherwise, such as to business days) shall be interpreted as a reference to a calendar day or number of calendar
days; reference to month or year means according to the Gregorian calendar; reference to a “company”, “corporate body” or “entity” shall include a, partnership, firm, company, corporation, limited
liability company, association, joint venture, trust, unincorporated organization, estate, or a government municipality or any political, governmental, regulatory or similar agency or body, and reference to a “person” shall mean any of the
foregoing or a natural person. 
  

	19.	 COUNTERPARTS 

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and enforceable against the parties
actually executing such counterpart, and all of which together shall constitute one and the same instrument; it being understood that parties need not sign the same counterpart. The exchange of an executed Agreement (in counterparts or otherwise) by
facsimile or by electronic delivery in pdf format shall be sufficient to bind the parties to the terms and conditions of this Agreement, as an original. 

[SIGNATURE PAGE TO FOLLOW] 

  
 - 8 - 

 IN WITNESS WHEREOF, the parties, each acting under due and proper authority, have
executed this Indemnification Agreement as of the date first mentioned above, in one or more counterparts. 
  

			
	Alpha Tau Medical Ltd.
		
	By:	 	  

		
	Name and title:	 	  

	
	Indemnitee:
		
	Name:	 	  

		
	Signature:	 	  

		
	Address:	 	  

  
 - 9 - 

 EXHIBIT A* 

CATEGORY OF INDEMNIFIABLE EVENT 
  

	1.	 Matters, events, occurrences or circumstances in connection or associated with relationships with Company
employees or consultants or any employee union or similar or comparable organization. 

  

	2.	 Matters, events, occurrences or circumstances in connection or associated with business relations of any kind
between the Company and its employees, independent contractors, customers, suppliers, partners, distributors, agents, resellers, representatives, licensors, licensees, service providers and other business associates. 

 

	3.	 Negotiations, execution, delivery and performance of agreements of any kind or nature and any decisions or
deliberations relating to actions or omissions relating to the foregoing; any acts, omissions or circumstances that do or may constitute or are alleged to constitute anti-competitive acts, acts of commercial wrongdoing, or failure to meet any
standard of conduct which is or may be applicable to such acts, omissions or circumstances. 

  

	4.	 Approval of and recommendation or information provided to shareholders with respect to any and all corporate
actions, including the approval of the acts of the Company’s management, their guidance and their supervision, matters relating to the approval of transactions with Office Holders (including, without limitation, all compensation related
matters) or shareholders, including controlling persons and claims and allegations of failure to exercise business judgment, reasonable level of proficiency, expertise, care or any other applicable standard, with respect to the foregoing or
otherwise with respect to the Company’s business, strategy, operations and prospective outlook, and any discussions, deliberations, reviews or other preparatory or preliminary phases relating to any of the foregoing. 

 

	5.	 Actions in connection with the development or testing of products developed by the Company, including without
limitation, the performance of pre-clinical and clinical trials on such, whether performed by the Company or by third parties on behalf of the Company, and/or in connection with the distribution,
commercialization, sale, license or use of such products, including without limitation in connection with professional liability and product liability claims and/or in connection with the procedure of obtaining regulatory approvals regarding such
products, whether in Israel or abroad. 

  

	6.	 Violation, infringement, misappropriation, dilution and other misuse of copyrights, patents, designs, trade
secrets, confidential information, proprietary information and any intellectual property rights, acts in connection with the registration, assertion or protection of rights to intellectual property and the defense of claims related to intellectual
property, breach of confidentiality obligations, acts in regard of invasion of privacy or any violation of privacy or privacy related right or regulation, including with respect to databases or handling, collection or use of private information,
acts in connection with slander and defamation, and claims in connection with publishing or providing any information, including any filings with any governmental authorities, whether or not required under any applicable laws. 

  
 - 10 - 

	7.	 Violations of or failure to comply with securities laws, and any regulations or other rules promulgated
thereunder, of any jurisdiction, including without limitation, claims under the U.S. Securities Act of 1933 or the U.S. Exchange Act of 1934 or under the Israeli Securities Law, fraudulent disclosure claims, failure to comply with any securities
authority or any stock exchange disclosure or other rules and any other claims relating to relationships with investors, debt holders, shareholders, optionholders, holders of any other equity or debt instrument of the Company, and otherwise with the
investment community (including without limitation any such claims relating to a merger, acquisition, change in control transaction, issuance of securities, restructuring, spin out, spin off, divestiture, recapitalization or any other transaction
relating to the corporate structure or organization of the Company); claims relating to or arising out of financing arrangements, any breach of financial covenants or other obligations towards investors, lenders or debt holders, class actions,
violations of laws requiring the Company to obtain regulatory and governmental licenses, permits and authorizations in any jurisdiction, including in connection with disclosure, offering or other transaction related documents; actions taken in
connection with the issuance, purchase, holding or disposition of any type of securities of Company, including, without limitation, the grant of options, warrants or other rights to purchase any of the same or any offering of the Company’s
securities (whether on behalf of the Company or on behalf of any holders of securities of the Company) to private investors, underwriters, resellers or to the public, and listing of such securities, or the offer by the Company to purchase securities
from the public or from private investors or other holders, and any undertakings, representations, warranties and other obligations related to any of the foregoing or to the Company’s status as a public company or as an issuer of securities.

  

	8.	 Liabilities arising in connection with any products or services developed, distributed, rendered, sold,
provided, licensed or marketed by the Company or any affiliate thereof, and any actions or omissions in connection with the distribution, provision, sale, marketing, license or use of such products or services, including without limitation in
connection with professional liability and product liability claims or regulatory or reputational matters. 

  

	9.	 The offering of securities by the Company (whether on behalf of itself or on behalf of any holder of securities
and any other person) to the public and/or to offerees or the offer by the Company to purchase securities from the public and/or from private investors or other holders pursuant to a prospectus, offering documents, agreements, notices, reports,
tenders and/or other processes. 

  

	10.	 Events, facts or circumstances in connection with change in ownership or in the structure of the Company, its
reorganization, dissolution, winding up, any other arrangements concerning creditors rights, merger, change in control, issuances of securities, restructuring, spin out, spin off, divestiture, recapitalization or any other transaction relating to
the corporate structure or organization of the Company, and the approval of failure to approve of any corporate actions and any matters relating to corporate governance, capital structure, articles of association or other charter or governance
documents, appointment or dismissal of office holders or compensation thereof and appointment or dismissal of auditors, internal auditor or any other person performing any services for the Company. 

 

	11.	 Any claim or demand made in connection with any transaction not in the ordinary course of business of the
Company, as well as the sale, lease, purchase or acquisition of, or the receipt or grant of any rights with respect to, any assets or business. 

  

	12.	 Any claim or demand made by any third party suffering any personal injury and/or bodily injury or damage to
business or personal property or any other type of damage through any act or omission attributed to the Company, or its employees, agents or other persons acting or allegedly acting on its behalf, including, without limitation, failure to make
proper safety arrangements for the Company or its employees and liabilities arising from any accidental or continuous damage or harm to the Company’s employees, its contractors, its guests and visitors as a result of an accidental or continuous
event, or employment conditions, permanent or temporary, in the Company’s offices. 

  
 - 11 - 

	13.	 Any claim or demand made directly or indirectly in connection with complete or partial failure, by the Company
or its directors, officers and employees, to pay, report, keep applicable records or otherwise, of any local or foreign federal, state, county, municipal or city taxes or other taxes or compulsory payments of any nature whatsoever, including,
without limitation, income, sales, use, transfer, excise, value added, registration, severance, stamp, occupation, customs, duties, real property, personal property, capital stock, social security, unemployment, disability, payroll or employee
withholding or other withholding, including any interest, penalty or addition thereto, whether disputed or not. 

  

	14.	 Any administrative, regulatory, judicial or civil actions orders, decrees, suits, demands, demand letters,
directives, claims, liens, investigations, proceedings or notices of noncompliance or violation by any governmental entity or other person alleging potential responsibility or liability (including potential responsibility or liability for costs of
enforcement investigation, cleanup, governmental response, removal or remediation, for natural resources damages, property damage, personal injuries or penalties or for contribution, indemnification, cost recovery, compensation or injunctive relief)
arising out of, based on or related to (a) the presence of, improper handling or safety precautions, release, spill, emission, leaning, dumping, pouring, deposit, disposal, discharge, leaching or migration into the environment (each a
“Release”) or threatened Release of, or exposure to, any hazardous, toxic, explosive or radioactive substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos-containing material,
polychlorinated biphenyls (“PCBs”) or PCB-containing materials or equipment, radon gas, infectious or medical wastes and all other substances or wastes of any nature regulated pursuant to any
environmental law, including but not limited to radioactivity or radioactive material, at any location, whether or not owned, operated, leased or managed by the Company or any of its subsidiaries, or (b) circumstances forming the
basis of any violation of any environmental law or environmental permit, license, registration or other authorization required under applicable environmental law. 

 

	15.	 Any administrative, regulatory or judicial actions, orders, decrees, suits, demands, demand letters,
directives, claims, liens, investigations, proceedings or notices of noncompliance or violation by any governmental or regulatory entity or authority or any other person alleging the failure to comply with any statute, law, ordinance, rule,
regulation, order or decree of any governmental entity applicable to the Company or any of its businesses, assets or operations, or the terms and conditions of any operating certificate or licensing agreement. 

 

	16.	 Participation and/or non-participation at Company Board meetings,
expression of opinion or view and/or voting and/or abstention from voting at Company Board meetings, including, in each case, any committee thereof, as well as expression of opinion publicly in connection with the service as an Office Holder.

  

	17.	 Review and approval of the Company’s financial statements and any specific items or matters within,
including any action, consent or approval related to or arising from the foregoing, including, without limitations, engagement of or execution of certificates for the benefit of third parties related to the financial statements.

  

	18.	 Violation of laws, rules or regulations requiring the Company to obtain regulatory and governmental licenses,
permits and authorizations (including without limitation relating to export, import, encryption, antitrust or competition authorities) or laws related to any governmental grants in any jurisdiction. 

 

	19.	 Resolutions and/or actions relating to investments in the Company and/or its subsidiaries and/or affiliated
companies and/or investment in corporate or other entities and/or investments in other traded or non-traded securities and/or any other form of investment. 

 

	20.	 Liabilities arising out of advertising, including misrepresentations regarding the Company’s products or
services and unlawful distribution of emails. 

  

	21.	 Management of the Company’s bank accounts, including money management, foreign currency deposits,
securities, loans and credit facilities, credit cards, bank guarantees, letters of credit, consultation agreements concerning investments including with portfolio managers, hedging transactions, options, futures, and the like. 

  
 - 12 - 

	22.	 All actions, consents and approvals, including any prior discussions, reviews and deliberations, relating to a
distribution of dividends, in cash or otherwise, or to any other “distribution” as such term is defined under the Companies Law. 

  

	23.	 Any administrative, regulatory, judicial, civil or criminal, actions orders, decrees, suits, demands, demand
letters, directives, claims, liens, investigations, proceedings or notices of noncompliance, violation or breaches alleging potential responsibility, liability, loss or damage (including potential responsibility or liability for costs of
enforcement, investigation, cleanup, governmental response, removal or remediation, property damage or penalties, or for contribution, indemnification, cost recovery, compensation or injunctive relief), whether alleged or claimed by customers,
consumers, regulators, shareholders or others, arising out of, based on or related to: (a) cyber security, cyber attacks, data loss or breaches, unauthorized access to information, data, or databases (including but not limited to any personally
identifiable information or private health information) and use or disclosure of information contained therein, not preventing or detecting the breach or failing to otherwise disclose or respond to the breach; (b) circumstances forming the
basis of any violation of any law, permit, license, registration or other authorization required under applicable law governing data security, data protection, network security, information systems, privacy or any cyber environment (including,
users, networks, devices, software, processes, information systems, databases, information in storage or transit, applications, services, and systems that can be connected directly or indirectly to networks); (c) failure to implement a reporting
system or control, or failure to monitor or oversee the operation of such a system; (d) data destruction, extortion, theft, hacking, and denial of service attacks; losses or liabilities to others caused by errors and omissions, failure to
safeguard data or defamation; or (e) security-audit, post-incident public relations and investigative expenses, criminal reward funds, data breach/privacy crisis management (including, management of an incident, investigation, remediation, data
subject notification, call management, credit checking for data subjects, legal costs, court attendance and regulatory fines), extortion liability (including, losses due to a threat of extortion, professional fees related to dealing with the
extortion), or network security liability (including, losses as a result of denial of access, costs related to data on third-parties and costs related to the theft of data on third-party systems). 

The Limit Amount for all Indemnifiable Persons during each relevant period referred to in Section 1.2 of the Indemnification Agreement for
all events described in this Exhibit A (in Sections 1-22 (inclusive) above), shall be the greater of: 

(a) twenty-five percent (25%) of the Company’s total shareholders’ equity according to the Company’s
most recent financial statements as of the time of the actual payment of indemnification; 
 (b) $100,000,000; 

(c) ten percent (10%) of the Company Total Market Cap (which shall mean the average closing price of the Company’s
ordinary shares over the 30 trading days prior to the actual payment of indemnification, multiplied by the total number of issued and outstanding shares of the Company as of the date of actual payment); and 

(d) in connection with or arising out of a public offering of the Company’s securities, the aggregate amount of
proceeds from the sale by the Company and/or any shareholder of Company’s securities in such offering. 
  

	*	 Any reference in this Exhibit A to the Company shall include the Company and any entity in which the Indemnitee
serves in a Corporate Capacity. 

  
 - 13 -EX-10.11

 Exhibit 10.11 

COMPENSATION POLICY 

ALPHA TAU MEDICAL LTD. 

Compensation Policy for Executive Officers and Directors 

(As Adopted on [_____], 2021) 

 A. Overview and Objectives 

 

	1.	 Introduction 

This document sets forth the Compensation Policy for Executive Officers and Directors (this “Compensation Policy” or
“Policy”) of Alpha Tau Medical Ltd. (“Alpha Tau” or the “Company”), in accordance with the requirements of the Companies Law, 5759-1999 and the regulations promulgated
thereunder (the “Companies Law”). 
 Compensation is a key component of Alpha Tau’s overall human capital strategy to
attract, retain, reward, and motivate highly skilled individuals that will enhance Alpha Tau’s value and otherwise assist Alpha Tau to reach its business and financial long-term goals. Accordingly, the structure of this Policy is established to
tie the compensation of each officer to Alpha Tau’s goals and performance. 
 For purposes of this Policy, “Executive
Officers” shall mean “Office Holders” as such term is defined in Section 1 of the Companies Law, excluding, unless otherwise expressly indicated herein, Alpha Tau’s directors. 

This policy is subject to applicable law and is not intended, and should not be interpreted as limiting or derogating from, provisions of
applicable law to the extent not permitted. 
 This Policy shall apply to compensation agreements and arrangements which will be approved
after the date on which this Policy is adopted and shall serve as Alpha Tau’s Compensation Policy for five (5) years, commencing as of its adoption, unless amended earlier. 

The Compensation Committee and the Board of Directors of Alpha Tau (the “Compensation Committee” and the
“Board”, respectively) shall review and reassess the adequacy of this Policy from time to time, as required by the Companies Law. 
  

	2.	 Objectives  

Alpha Tau’s objectives and goals in setting this Policy are to attract, motivate and retain experienced and talented leaders who will
contribute to Alpha Tau’s success and enhance shareholder value, while demonstrating professionalism in an achievement-oriented and merit-based culture that rewards long-term excellence, and embedding and modeling Alpha Tau’s core values
as part of a motivated behavior. To that end, this Policy is designed, among other things: 
  

	 	2.1.	 To closely align the interests of the Executive Officers with those of Alpha Tau’s shareholders in order
to enhance shareholder value; 

  

	 	2.2.	 To align a significant portion of the Executive Officers’ compensation with Alpha Tau’s short and
long-term goals and performance; 

  

	 	2.3.	 To provide the Executive Officers with a structured compensation package, including competitive salaries,
performance-motivating cash and equity incentive programs and benefits, and to be able to present to each Executive Officer an opportunity to advance in a growing organization; 

 

	 	2.4.	 To strengthen the retention and the motivation of Executive Officers in the long-term; 

 

	 	2.5.	 To provide appropriate awards in order to incentivize superior individual excellence and corporate performance;
and 

  

	 	2.6.	 To maintain consistency in the way Executive Officers are compensated. 

  
 2 

	3.	 Compensation Instruments 

Compensation instruments under this Policy may include the following: 
  

	 	3.1.	 Base salary; 

  

	 	3.2.	 Benefits; 

  

	 	3.3.	 Cash bonuses; 

  

	 	3.4.	 Equity based compensation; 

 

	 	3.5.	 Change of control provisions; and 

 

	 	3.6.	 Retirement and termination terms. 

 

	4.	 Overall Compensation - Ratio Between Fixed and Variable Compensation 

 

	 	4.1.	 This Policy aims to balance the mix of “Fixed Compensation” (comprised of base salary and benefits)
and “Variable Compensation” (comprised of cash bonuses and equity-based compensation) in order to, among other things, appropriately incentivize Executive Officers to meet Alpha Tau’s short and long-term goals while taking into
consideration the Company’s need to manage a variety of business risks. 

  

	 	4.2.	 The total annual target bonus and equity-based compensation per vesting annum (based on the fair market value
at the time of grant calculated on a linear basis) of each Executive Officer shall not exceed 95% of such Executive Officer’s total compensation package for such year. 

 

	5.	 Inter-Company Compensation Ratio 

 

	 	5.1.	 In the process of drafting this Policy, Alpha Tau’s Board and Compensation Committee have examined the
ratio between employer cost associated with the engagement of the Executive Officers, including directors, and the average and median employer cost associated with the engagement of Alpha Tau’s other employees (including contractor employees as
defined in the Companies Law) (the “Ratio”). 

  

	 	5.2.	 The possible ramifications of the Ratio on the daily working environment in Alpha Tau were examined and will
continue to be examined by Alpha Tau from time to time in order to ensure that levels of executive compensation, as compared to the overall workforce will not have a negative impact on work relations in Alpha Tau. 

B. Base Salary and Benefits 
  

	6.	 Base Salary 

  

	 	6.1.	 A base salary provides stable compensation to Executive Officers and allows Alpha Tau to attract and retain
competent executive talent and maintain a stable management team. The base salary varies among Executive Officers, and is individually determined according to the educational background, prior vocational experience, qualifications, corporate
role, business responsibilities and past performance of each Executive Officer. 

  

	 	6.2.	 Since a competitive base salary is essential to Alpha Tau’s ability to attract and retain highly skilled
professionals, Alpha Tau will seek to establish a base salary that is competitive with base salaries paid to Executive Officers in a peer group of other companies operating in sectors that are as much as possible similar in their characteristics to
Alpha Tau the list of which shall be reviewed and approved by the Compensation Committee. To that end, Alpha Tau shall utilize comparative market data and practices as a reference, including a survey comparing and analyzing the level of the overall
compensation package offered to an Executive Officer of the Company with compensation packages for persons serving in similar positions (to that of the relevant officer) in the peer group. Such compensation survey may be conducted internally or
through an external independent consultant. 

  
 3 

	 	6.3.	 The Compensation Committee and the Board may periodically consider and approve base salary adjustments for
Executive Officers. The main considerations for salary adjustment will be similar to those used in initially determining the base salary, but may also include change of role or responsibilities, recognition for professional achievements, regulatory
or contractual requirements, budgetary constraints or market trends. The Compensation Committee and the Board will also consider the previous and existing compensation arrangements of the Executive Officer whose base salary is being considered for
adjustment. Any limitation herein based on the annual base salary shall be calculated based on the monthly base salary applicable at the time of consideration of the respective grant or benefit. 

 

	7.	 Benefits 

  

	 	7.1.	 The following benefits may be granted to the Executive Officers in order, among other things, to comply with
legal requirements: 

  

	 	7.1.1.	 Vacation days in accordance with market practice; 

 

	 	7.1.2.	 Sick days in accordance with market practice; 

 

	 	7.1.3.	 Convalescence pay according to applicable law; 

 

	 	7.1.4.	 Monthly remuneration for a study fund, as allowed by applicable law and with reference to Alpha Tau’s
practice and the practice in peer group companies (including contributions on bonus payments); 

  

	 	7.1.5.	 Alpha Tau shall contribute on behalf of the Executive Officer to an insurance policy or a pension fund, as
allowed by applicable law and with reference to Alpha Tau’s policies and procedures and the practice in peer group companies (including contributions on bonus payments); and 

 

	 	7.1.6.	 Alpha Tau shall contribute on behalf of the Executive Officer towards work disability insurance, as allowed by
applicable law and with reference to Alpha Tau’s policies and procedures and to the practice in peer group companies. 

  

	 	7.2.	 Non-Israeli Executive Officers may receive other similar, comparable or
customary benefits as applicable in the relevant jurisdiction in which they are employed. Such customary benefits shall be determined based on the methods described in Section 6.2 of this Policy (with the necessary changes and adjustments).

  

	 	7.3.	 In the events of relocation and/or repatriation of an Executive Officer to another geography, such Executive
Officer may receive other similar, comparable or customary benefits as applicable in the relevant jurisdiction in which he or she is employed or additional payments to reflect adjustments in the cost of living. Such benefits may include
reimbursement for out-of-pocket one-time payments and other ongoing expenses, such as a housing allowance, a car allowance, home
leave visit, etc. 

  

	 	7.4.	 Alpha Tau may offer additional benefits to its Executive Officers, which will be comparable to customary market
practices, such as, but not limited to: cellular and land line phone benefits, company car and travel benefits, reimbursement of business travel including a daily stipend when traveling and other business related expenses, insurances, other
benefits (such as meals in the office, newspaper subscriptions, academic and professional studies), etc., provided, however, that such additional benefits shall be determined in accordance with Alpha Tau’s policies and procedures.

 C. Cash Bonuses 
  

	8.	 Annual Cash Bonuses - The Objective 

 

	 	8.1.	 Compensation in the form of an annual cash bonus is an important element in aligning the Executive
Officers’ compensation with Alpha Tau’s objectives and business goals. 

  
 4 

	 	
Therefore, annual cash bonuses will reflect a pay-for-performance element, with payout eligibility and levels
determined based on actual financial and operational results, in addition to other factors the Compensation Committee may determine, including individual performance. 

 

	 	8.2.	 An annual cash bonus may be awarded to Executive Officers upon the attainment of
pre-set periodical objectives and individual targets determined by the Compensation Committee (and, if required by law, by the Board) for each fiscal year, or in connection with such officer’s engagement,
in case of newly hired Executive Officers, taking into account Alpha Tau’s short and long-term goals, as well as its compliance and risk management policies. The Compensation Committee and the Board shall also determine applicable minimum
thresholds that must be met for entitlement to the annual cash bonus (all or any portion thereof) and the formula for calculating any annual cash bonus payout, with respect to each fiscal year, for each Executive Officer. In special circumstances,
as determined by the Compensation Committee and the Board (e.g., regulatory changes, significant changes in Alpha Tau’s business environment, a significant organizational change, significant merger and acquisition events, etc.), the
Compensation Committee and the Board may modify the objectives and/or their relative weight during the fiscal year, or may modify payouts following the conclusion of the year. 

 

	 	8.3.	 In the event that the employment of an Executive Officer is terminated prior to the end of a fiscal year, the
Company may (but shall not be obligated to) pay such Executive Officer an annual cash bonus (which may or may not be pro-rated) assuming the Executive Officer is otherwise entitled to an annual cash bonus.

  

	 	8.4.	 The actual annual cash bonus to be paid to Executive Officers shall be approved by the Compensation Committee
and the Board. 

  

	9.	 Annual Cash Bonuses—The Formula 

Executive Officers other than the CEO 
  

	 	9.1.	 The performance objectives for the annual cash bonus of Alpha Tau’s Executive Officers, other than the
chief executive officer (the “CEO”), may be approved by Alpha Tau’s CEO (in lieu of the Compensation Committee) and may be based on company and individual objectives. Measurable performance objectives will include the
objectives and the weight to be assigned to each achievement in the overall evaluation, and will be based on actual results. The Company may also grant annual cash bonuses to Alpha Tau’s Executive Officers, other than the CEO, on a
discretionary basis. 

  

	 	9.2.	 The target annual cash bonus that an Executive Officer, other than the CEO, will be entitled to receive for any
given fiscal year, will not exceed 100 % of such Executive Officer’s annual base salary. 

  

	 	9.3.	 The maximum annual cash bonus, including for overachievement performance, that an Executive Officer, other than
the CEO, will be entitled to receive for any given fiscal year, will not exceed 200 % of such Executive Officer’s annual base salary. 

CEO 
  

	 	9.4.	 The annual cash bonus of Alpha Tau’s CEO will be mainly based on measurable performance objectives and
subject to minimum thresholds as provided in Section 8.2 above. Such measurable performance objectives will be determined annually by Alpha Tau’s Compensation Committee (and, if required by law, by Alpha Tau’s Board) and will be based
on company and personal objectives. These measurable performance objectives, which include the objectives and the weight to be assigned to each achievement in the overall evaluation, will be based on overall company performance measures, which are
based on actual financial and operational results. 

  
 5 

	 	9.5.	 The less significant part of the annual cash bonus granted to Alpha Tau’s CEO, and in any event not more
than 40% of the annual cash bonus, may be based on a discretionary evaluation of the CEO’s overall performance by the Compensation Committee and the Board based on quantitative and qualitative criteria. 

 

	 	9.6.	 The target annual cash bonus that the CEO will be entitled to receive for any given fiscal year, will not
exceed 100% of his or her annual base salary. 

  

	 	9.7.	 The maximum annual cash bonus including for overachievement performance that the CEO will be entitled to
receive for any given fiscal year, will not exceed 200 % of his or her annual base salary. 

  

	10.	 Other Bonuses 

 

	 	10.1.	 Special Bonus. Alpha Tau may grant its Executive Officers a special bonus as an award for special
achievements (such as in connection with mergers and acquisitions, offerings, achieving target budget or business plan objectives under exceptional circumstances, or special recognition in case of retirement) or as a retention award at the
CEO’s discretion for Executive Officers other than the CEO (and in the CEO’s case, at the Compensation Committee’s and the Board’s discretion), subject to any additional approval as may be required by the Companies Law (the
“Special Bonus”). Any such Special Bonus will not exceed 200 % of the Executive Officer’s annual base salary. A Special Bonus can be paid, in whole or in part, in equity in lieu of cash and the value of any such equity
component of a Special Bonus shall be determined in accordance with Section 13.3 below. 

  

	 	10.2.	 Signing Bonus. Alpha Tau may grant a newly recruited Executive Officer a signing bonus. Any such signing
bonus shall be granted and determined at the CEO’s discretion for Executive Officers other than the CEO (and in the CEO’s case, at the Compensation Committee’s and the Board’s discretion), subject to any additional approval as
may be required by the Companies Law (the “Signing Bonus”). Any such Signing Bonus will not exceed 100 % of the Executive Officer’s annual base salary. 

 

	 	10.3.	 Relocation/ Repatriation Bonus. Alpha Tau may grant its Executive Officers a special bonus in the event
of relocation or repatriation of an Executive Officer to another geography (the “Relocation Bonus”). Any such Relocation bonus will include customary benefits associated with such relocation and its monetary value will not exceed
100 % of the Executive Officer’s annual base salary. 

  

	11.	 Compensation Recovery (“Clawback”) 

 

	 	11.1.	 In the event of an accounting restatement, Alpha Tau shall be entitled to recover from its Executive Officers
the bonus compensation or performance-based equity compensation in the amount in which such compensation exceeded what would have been paid based on the financial statements, as restated, provided that a claim is made by Alpha Tau prior to the
second anniversary following the filing of such restated financial statements. 

  

	 	11.2.	 Notwithstanding the aforesaid, the compensation recovery will not be triggered in the following events:

  

	 	11.2.1.	 The financial restatement is required due to changes in the applicable financial reporting standards; or

  

	 	11.2.2.	 The Compensation Committee has determined that Clawback proceedings in the specific case would be impossible,
impractical, or not commercially or legally efficient. 

  

	 	11.3.	 Nothing in this Section 11 derogates from any other “Clawback” or similar provisions regarding
disgorging of profits imposed on Executive Officers by virtue of applicable securities laws or a separate contractual obligation. 

  
 6 

 D. Equity Based Compensation 

 

	12.	 The Objective 

 

	 	12.1.	 The equity-based compensation for Alpha Tau’s Executive Officers will be designed in a manner consistent
with the underlying objectives of the Company in determining the base salary and the annual cash bonus, with its main objectives being to enhance the alignment between the Executive Officers’ interests with the long-term interests of Alpha Tau
and its shareholders, and to strengthen the retention and the motivation of Executive Officers in the long term. In addition, since equity-based awards are structured to vest over several years, their incentive value to recipients is aligned with
longer-term strategic plans. 

  

	 	12.2.	 The equity-based compensation offered by Alpha Tau is intended to be in the form of share options and/or other
equity-based awards, such as restricted shares, RSUs or performance stock units, in accordance with the Company’s equity incentive plan in place as may be updated from time to time. 

 

	 	12.3.	 All equity-based incentives granted to Executive Officers (other than bonuses paid in equity in lieu of cash)
shall normally be subject to vesting periods in order to promote long-term retention of the awarded Executive Officers. Unless determined otherwise in a specific award agreement or in a specific compensation plan approved by the Compensation
Committee and the Board, grants to Executive Officers other than non-employee directors shall vest based on time, gradually over a period of at least 2-4 years, or based
on performance. The exercise price of options shall be determined in accordance with Alpha Tau’s policies, the main terms of which shall be disclosed in the annual report of Alpha Tau. 

 

	 	12.4.	 All other terms of the equity awards shall be in accordance with Alpha Tau’s incentive plans and other
related practices and policies. Accordingly, the Board may, following approval by the Compensation Committee, make modifications to such awards consistent with the terms of such incentive plans, including acceleration of awards, subject to any
additional approval as may be required by the Companies Law. 

  

	13.	 General Guidelines for the Grant of Awards 

 

	 	13.1.	 The equity-based compensation shall be granted from time to time and be individually determined and awarded
according to the performance, educational background, prior business experience, qualifications, corporate role and the personal responsibilities of the Executive Officer. 

 

	 	13.2.	 In determining the equity-based compensation granted to each Executive Officer, the Compensation Committee and
the Board shall consider the factors specified in Section 13.1 above, and in any event, the total fair market value of an annual equity-based compensation award at the time of grant (not including bonuses paid in equity in lieu of cash) shall
not exceed: (i) with respect to the CEO - 325% of his or her annual base salary; and (ii) with respect to each of the other Executive Officers - 215% of his or her annual base salary. 

 

	 	13.3.	 The fair market value of the equity-based compensation for the Executive Officers will be determined by
multiplying the number of shares underlying the grant by the market price of Alpha Tau’s ordinary shares on or around the time of the grant or according to other acceptable valuation practices at the time of grant, in each case, as determined
by the Compensation Committee and the Board. 

 E. Retirement and Termination of Service Arrangements 

 

	14.	 Advanced Notice Period 

Alpha Tau may provide an Executive Officer, on the basis of his/her seniority in the Company, his/her contribution to the Company’s goals
and achievements and the circumstances of his/her retirement prior notice of termination of up to twelve (12) months in the case of the CEO and six (6) months in the case of other Executive Officers, during which the Executive Officer may
be entitled 

  
 7 

 
to all of the compensation elements, and to the continuation of vesting of his/her equity-based compensation. Such advance notice may or may not be provided in addition to severance, provided,
however, that the Compensation Committee shall take into consideration the Executive Officer’s entitlement to advance notice in establishing any entitlement to severance and vice versa. 

 

	15.	 Adjustment Period 

Alpha Tau may provide an additional adjustment period of up to six (6) months to the CEO or to any other Executive Officer according to
his/her seniority in the Company, his/her contribution to the Company’s goals and achievements and the circumstances of retirement, during which the Executive Officer may be entitled to all of the compensation elements, and to the continuation
of vesting of his/her equity-based compensation. 
  

	16.	 Additional Retirement and Termination Benefits 

Alpha Tau may provide additional retirement and terminations benefits and payments as may be required by applicable law (e.g., mandatory
severance pay under Israeli labor laws), or which will be comparable to customary market practices. 
  

	17.	 Non-Compete Grant 

Upon termination of employment and subject to applicable law, Alpha Tau may grant to its Executive Officers a
non-compete grant as an incentive to refrain from competing with Alpha Tau for a defined period of time. The terms and conditions of the non-compete grant shall be
decided by the Board and shall not exceed such Executive Officer’s monthly base salary multiplied by twelve (12). The Board shall consider the existing entitlements of the Executive Officer in connection with the consideration of any non-compete grant. 
  

	18.	 Limitation Retirement and Termination of Service Arrangements 

The total non-statutory payments under Section 14-17 above
for a given Executive Officer shall not exceed the Executive Officer’s monthly base salary multiplied by twenty-four (24). The limitation under this Section 18 does not apply to benefits and payments provided under other chapters of this
Policy. 
 F. Exculpation, Indemnification and Insurance 
  

	19.	 Exculpation 

Each and every Director and Executive Officer may be exempted in advance for all or any of his/her liability for damage in consequence of a
breach of the duty of care, to the fullest extent permitted by applicable law. 
  

	20.	 Insurance and Indemnification 

 

	 	20.1.	 Alpha Tau may indemnify its directors and Executive Officers to the fullest extent permitted by applicable law,
for any liability and expense that may be imposed on the director or the Executive Officer, as provided in the indemnity agreement between such individuals and Alpha Tau all subject to applicable law and the Company’s articles of association.

  

	 	20.2.	 Alpha Tau will provide directors’ and officers’ liability insurance (the “Insurance
Policy”) for its directors and Executive Officers as follows: 

  

	 	20.2.1.	 The limit of liability of the insurer shall not exceed the greater of $50 million or 50% of the
Company’s shareholders equity based on the most recent financial statements of the Company at the time of approval of the Insurance Policy by the Compensation Committee; and 

  
 8 

	 	20.2.2.	 The Insurance Policy, as well as the limit of liability and the premium for each extension or renewal shall be
approved by the Compensation Committee (and, if required by law, by the Board) which shall determine that the sums are reasonable considering Alpha Tau’s exposures, the scope of coverage and the market conditions and that the Insurance Policy
reflects the current market conditions and that it shall not materially affect the Company’s profitability, assets or liabilities. 

  

	 	20.3.	 Upon circumstances to be approved by the Compensation Committee (and, if required by law, by the Board), Alpha
Tau shall be entitled to enter into a “run off” Insurance Policy (the “Run-Off Policy”) of up to seven (7) years, with the same insurer or any other insurance, as follows:

  

	 	20.3.1.	 The limit of liability of the insurer shall not exceed the greater of $50 million or 50% of the
Company’s shareholders equity based on the most recent financial statements of the Company at the time of approval by the Compensation Committee; and 

  

	 	20.3.2.	 The Run-Off Policy, as well as the limit of liability and the premium
for each extension or renewal shall be approved by the Compensation Committee (and, if required by law, by the Board) which shall determine that the sums are reasonable considering the Company’s exposures covered under such policy, the scope of
coverage and the market conditions and that the Run-Off Policy reflects the current market conditions and that it shall not materially affect the Company’s profitability, assets or liabilities.

  

	 	20.4.	 Alpha Tau may extend an Insurance Policy in effect to include coverage for liability pursuant to a future
public offering of securities as follows: 

  

	 	20.4.1.	 The Insurance Policy, as well as the additional premium shall be approved by the Compensation Committee (and if
required by law, by the Board) which shall determine that the sums are reasonable considering the exposures pursuant to such public offering of securities, the scope of coverage and the market conditions and that the Insurance Policy reflects the
current market conditions, and that it does not materially affect the Company’s profitability, assets or liabilities. 

 G.
Arrangements upon Change of Control 
  

	21.	 The following benefits may be granted to the Executive Officers (in addition to, or in lieu of, the
benefits applicable in the case of any retirement or termination of service) upon or in connection with a “Change of Control” or, where applicable, in the event of a Change of Control following which the employment
of the Executive Officer is terminated or adversely adjusted in a material way: 

  

	 	21.1.	 Acceleration of vesting of outstanding options or other equity-based awards; 

 

	 	21.2.	 Extension of the exercise period of equity-based grants for Alpha Tau’s Executive Officers for a period of
up to one (1) year, following the date of termination of employment; and 

  

	 	21.3.	 Up to an additional six (6) months of continued base salary and benefits following the date of termination
of employment, or twelve (12) months in the case of the CEO (the “Additional Adjustment Period”). For avoidance of doubt, such additional Adjustment Period may be in addition to the advance notice and adjustment periods
pursuant to Sections 14 and 15 of this Policy, but subject to the limitation set forth in Section 18 of this Policy. 

  

	 	21.4.	 A cash bonus not to exceed 200% of the Executive Officer’s annual base salary in case of an Executive
Officer other than the CEO and 250% in case of the CEO. 

 H. Board of Directors Compensation 

 

	22.	 All Alpha Tau’s non-employee Board members may be entitled to an
annual cash fee retainer of up to $30,000 (and up to $50,000 for the chairperson of Alpha Tau’s Board or lead independent director), an annual committee membership fee retainer of up to $20,000, and an annual committee chairperson cash fee
retainer of up to $25,000 (it is being clarified that the payment for the chairpersons would be in lieu of (and not in addition) to the payments referenced above for committee membership). 

  
 9 

	23.	 The compensation of the Company’s external directors, if any are required and elected, shall be in
accordance with the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director), 5760-2000, as amended by the Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel),
5760-2000, as such regulations may be amended from time to time. 

  

	24.	 Notwithstanding the provisions of Section 22 above, in special circumstances, such as in the case of a
professional director, an expert director or a director who makes a unique contribution to the Company, such director’s compensation may be different than the compensation of all other directors and may be greater than the maximum amount
allowed under Section 22. 

  

	25.	 Each non-employee member of Alpha Tau’s Board may be granted
equity-based compensation. The total fair market value of a “welcome” or an annual equity-based compensation at the time of grant shall not exceed $150,000 at the time of approval of the grant by the Board. 

 

	26.	 All other terms of the equity awards shall be in accordance with Alpha Tau’s incentive plans and other
related practices and policies. Accordingly, the Board may, following approval by the Compensation Committee, make modifications to such awards consistent with the terms of such incentive plans, subject to any additional approval as may be required
by the Companies Law. 

  

	27.	 In addition, members of Alpha Tau’s Board may be entitled to reimbursement of expenses in connection with
the performance of their duties. 

  

	28.	 The compensation (and limitations) stated under Section H will not apply to directors who serve as Executive
Officers. 

 I. Miscellaneous 
  

	29.	 Nothing in this Policy shall be deemed to grant to any of Alpha Tau’s Executive Officers, employees,
directors, or any third party any right or privilege in connection with their employment by or service to the Company, nor deemed to require Alpha Tau to provide any compensation or benefits to any person. Such rights and privileges shall be
governed by applicable personal employment agreements or other separate compensation arrangements entered into between Alpha Tau and the recipient of such compensation or benefits. The Board may determine that none or only part of the payments,
benefits and perquisites detailed in this Policy shall be granted, and is authorized to cancel or suspend a compensation package or any part of it. 

  

	30.	 An Immaterial Change in the Terms of Employment of an Executive Officer other than the CEO may be approved by
the CEO, provided that the amended terms of employment are in accordance with this Policy. An “Immaterial Change in the Terms of Employment” means a change in the terms of employment of an Executive Officer with an annual total cost to the
Company not exceeding an amount equal to two (2) monthly base salaries of such employee. 

  

	31.	 In the event that new regulations or law amendment in connection with Executive Officers’ and
directors’ compensation will be enacted following the adoption of this Policy, Alpha Tau may follow such new regulations or law amendments, even if such new regulations are in contradiction to the compensation terms set forth herein.

 ********************* 

This Policy is designed solely for the benefit of Alpha Tau and none of the provisions thereof are intended to provide any rights or remedies to any person
other than Alpha Tau. 

  
 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]